Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer.

about

Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q36142343

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@ast

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@en

type

Item

label

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@ast

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@en

prefLabel

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@ast

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@en

P1476

Phase I study of docetaxel plu ...... nt non-small cell lung cancer.

@en

P2093

Hiroshi Iwamoto

http://www.w3.org/2001/XMLSchema#string

Hiroshi Murai

http://www.w3.org/2001/XMLSchema#string

Kazunori Fujitaka

http://www.w3.org/2001/XMLSchema#string

Masashi Kanehara

http://www.w3.org/2001/XMLSchema#string

Noboru Hattori

http://www.w3.org/2001/XMLSchema#string

Nobuhisa Ishikawa

http://www.w3.org/2001/XMLSchema#string

Nobuoki Kohno

http://www.w3.org/2001/XMLSchema#string

Shinichiro Ohshimo

http://www.w3.org/2001/XMLSchema#string

Tadashi Senoo

http://www.w3.org/2001/XMLSchema#string

Yoshinori Haruta

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline.

Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer.

Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.

Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.

Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID mice.

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

P304

167-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2010.218

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230624408

http://www.w3.org/2001/XMLSchema#string

P698

22870147

http://www.w3.org/2001/XMLSchema#string

P932

3412446

http://www.w3.org/2001/XMLSchema#string